IMMUNE PHARMACEUTICALS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$2.4M

320 transactions

Summary

IMMUNE PHARMACEUTICALS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $2.4MSales: $039 insiders

Date	Insider	Type	Value
2016-08-04	Teper Daniel Gedeon(CEO)	Buy	$356K
2016-08-04	Teper Daniel Gedeon(CEO)	Buy	$356K
2016-08-04	Luchi Monica E.(EVP & CMO)	Buy	$350K
2016-08-04	Kazado Daniel	Buy	$300K
2016-12-16	Kazado Daniel	Buy	$31K
2017-01-04	Kazado Daniel	Buy	$15K
2018-05-17	Fiorino Anthony S.(Chief Medical Officer and COO)	Buy	$13K
2016-10-06	Teper Daniel Gedeon(CEO)	M	$7K
2018-05-22	Fiorino Anthony S.(Chief Medical Officer and COO)	Buy	$6K
2020-02-03	Fiorino Anthony S.	Sell	$0
2017-09-14	Fiorino Anthony S.(Chief Medical Officer and COO)	A	$0
2017-07-18	Maza Elliot M(Interim CEO)	A	$0
2017-01-26	Kimball Ranch C	A	$0
2017-01-25	Durrant Cameron	A	$0
2017-01-25	Kazado Daniel	A	$0
2017-01-25	Maza Elliot M	A	$0
2017-01-25	Neczesny John A.	A	$0
2017-01-25	Paley Jeffrey	A	$0
2016-10-06	Teper Daniel Gedeon(CEO)	M	$0
2016-06-24	Teper Daniel Gedeon(CEO)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

IMMUNE PHARMACEUTICALS INC — Contributions, Lobbying & Contracts | Poliscope